Press Release: Sanofi Delivers Solid Sales and Business EPS

Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline Paris, February 1, 2024 Q4 2023 sales growth of 9.3% at CER and...

Related Keywords

China , Paris , France General , France , Paul Hudson , Impact Fund , Sanofi Global Health Unit , Sanofi Delivers Solid Sales , Successful Product Launches , Immunology Pipeline , Digestive Wellness , Mental Wellness , Chronic Obstructive Pulmonary Disease , Multiple Myeloma , Corporate Social Responsibility , Global Health Unit , Sanofi Chief Executive Officer , Specialty Care , Markets ,